Sionna Therapeutics Income Statement (2024-2026) | SION

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter) 10.22M8.23M24.58M14.25M13.67M15.38M16.04M15.17M18.96M
Selling, General & Administrative (Quarter) 2.93M3.06M3.40M3.88M5.99M6.52M7.76M8.44M10.64M
Operating Expenses (Quarter) 13.15M11.29M27.98M18.13M19.66M21.91M23.80M23.61M29.60M
Operating Income (Quarter) -13.15M-11.29M-27.98M-18.13M-19.66M-21.91M-23.80M-23.61M-29.60M
EBIT (Quarter) -13.15M-11.29M-27.98M-18.13M-19.66M-21.91M-23.80M-23.61M-29.60M
Non-operating items
Interest & Investment Income (Quarter) 1.13M2.57M2.35M2.12M3.00M3.67M3.46M3.17M2.82M
Other Non Operating Income (Quarter) 0.17M0.17M0.19M0.17M0.18M0.17M0.07M
Non Operating Income (Quarter) 1.30M2.74M2.54M2.29M3.18M3.84M3.53M3.17M2.82M
Net income details
EBT (Quarter) -12.02M-8.73M-25.63M-67.62M-16.66M-18.24M-20.35M-188.45M-26.78M
Profit After Tax (Quarter) -11.85M-8.55M0.93M-16.62M-16.48M-18.07M-20.04M-20.27M-0.62M
Income from Continuing Operations (Quarter) -12.02M-8.73M-25.63M-67.62M-16.66M-18.24M-20.35M-188.45M-26.78M
Consolidated Net Income (Quarter) -12.02M-8.73M-25.63M-67.62M-16.66M-18.24M-20.35M-188.45M-26.78M
Income towards Parent Company (Quarter) -12.02M-8.73M-25.63M-67.62M-16.66M-18.24M-20.35M-188.45M-26.78M
Net Income towards Common Stockholders (Quarter) -12.02M-8.73M-25.63M-67.62M-16.66M-18.24M-20.35M-188.45M-26.78M
Additional items
EPS (Basic) (Quarter) -3.90-2.76-5.71-17.52-0.63-0.41-0.46-4.72-0.60
EPS (Diluted) (Quarter) -3.90-2.76-5.71-17.52-0.63-0.41-0.46-4.72-0.60
Shares Outstanding (Quarter) 3.08M3.16M4.49M3.86M26.60M44.12M44.26M39.96M44.92M
Shares Outstanding (Diluted) (Quarter) 3.08M3.16M4.49M3.86M26.60M44.12M44.26M39.96M44.92M
EBITDA (Quarter) -13.15M-11.29M-27.98M-18.13M-19.66M-21.91M-23.80M-23.61M-29.60M
Interest Expenses (Quarter) 51.61M168.01M